Semaglutide Protects Retinal Ganglion Cells Against Rotenone-Induced Degeneration via Improved Glucose Metabolism.

Mouhammad, Zaynab A et al.·Investigative ophthalmology & visual science·2026·

Quick Facts

Study Type

Not classified

Evidence

Not graded

Sample

Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:: Semaglutide Protects Retinal Ganglion Cells Against Rotenone-Induced Degeneration via Improved Glucose Metabolism.
Published In:: Investigative ophthalmology & visual science, 67(2), 25 (2026)
Authors:: Mouhammad, Zaynab A, Tribble, James R, Nicol, Alan, Andreopoulou, Evgenia, García-Bermúdez, Mariana Y, Aldana, Blanca I, Vohra, Rupali, Kolko, Miriam, Williams, Pete A
Database ID:: RPEP-15751

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

What do these levels mean? →

Cite This Study

RPEP-15751·https://rethinkpeptides.com/research/RPEP-15751

APA

Mouhammad, Zaynab A; Tribble, James R; Nicol, Alan; Andreopoulou, Evgenia; García-Bermúdez, Mariana Y; Aldana, Blanca I; Vohra, Rupali; Kolko, Miriam; Williams, Pete A. (2026). Semaglutide Protects Retinal Ganglion Cells Against Rotenone-Induced Degeneration via Improved Glucose Metabolism.. Investigative ophthalmology & visual science, 67(2), 25. https://doi.org/10.1167/iovs.67.2.25

MLA

Mouhammad, Zaynab A, et al. "Semaglutide Protects Retinal Ganglion Cells Against Rotenone-Induced Degeneration via Improved Glucose Metabolism.." Investigative ophthalmology & visual science, 2026. https://doi.org/10.1167/iovs.67.2.25

RethinkPeptides

RethinkPeptides Research Database. "Semaglutide Protects Retinal Ganglion Cells Against Rotenone..." RPEP-15751. Retrieved from https://rethinkpeptides.com/research/mouhammad-2026-semaglutide-protects-retinal-ganglion

Access the Original Study

View on PubMed View via DOI

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database